Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank50
3Y CAGR-43.1%
5Y CAGR+7.3%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
-43.1%/yr
Annual compound
5Y CAGR
+7.3%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025$474000.00-
2024$0.00-100.0%
2023$2.07M-19.5%
2022$2.57M+47.8%
2021$1.74M+422.8%
2020$333000.00+33200.0%
2019$1000.00-